ArticleThe oncologist2025

Real-life follow-up after discontinuation of anti-PD1 therapy for complete-response cutaneous squamous cell carcinoma in patients over 75 years of age.

Julie Lardenois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.